Literature DB >> 27514853

Contribution of Aspartic Proteases in Candida Virulence. Protease Inhibitors against Candida Infections.

Staniszewska Monika1, Bondaryk Małgorzata1, Ochal Zbigniew2.   

Abstract

Candida species are the major opportunistic human pathogens accounting for 70-90% of all invasive fungal infections. Candida spp, especially C. albicans, are able to produce and secrete hydrolytic enzymes, particularly aspartic proteases (Saps). These enzymes production is an evolutionary adaptation of pathogens to utilize nutrients and survive in host. Sap1-10 are believed to contribute to the adhesion and invasion of host tissues through the degradation of cell surface structures. Aspartic proteases control several steps in innate immune evasion and they degrade proteins related to immunological defense (antibodies, complement and cytokines), allowing the fungus to escape from the first line of host defense. The existing ways to identify potential drug targets rely on specific subset like virulence genes, transcriptional and stress response factors. Candida virulence factors like Sap isoenzymes can be pivotal targets for drug development. The identification of mechanism of a non-canonical inflammasome exerted by Saps could open novel therapeutic strategies to dampen hyperinflammatory response in candidiasis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Candida; Sap1-10; enzymes; fungal infections; inhibitors; pathogenesis

Mesh:

Substances:

Year:  2017        PMID: 27514853     DOI: 10.2174/1389203717666160809155749

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  8 in total

1.  Interactions of Extracellular Vesicles from Pathogenic Fungi with Innate Leukocytes.

Authors:  Mateus Silveira Freitas; Andre Moreira Pessoni; Carolina Coelho; Vânia Luiza Deperon Bonato; Marcio L Rodrigues; Arturo Casadevall; Fausto Almeida
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

2.  The Search for Cryptic L-Rhamnosyltransferases on the Sporothrix schenckii Genome.

Authors:  Héctor M Mora-Montes; Karina García-Gutiérrez; Laura C García-Carnero; Nancy E Lozoya-Pérez; Jorge H Ramirez-Prado
Journal:  J Fungi (Basel)       Date:  2022-05-20

3.  Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of Candida glabrata.

Authors:  Maria Helena Galdino Figueiredo-Carvalho; Lívia de Souza Ramos; Leonardo Silva Barbedo; Jean Carlos Almeida de Oliveira; André Luis Souza Dos Santos; Rodrigo Almeida-Paes; Rosely Maria Zancopé-Oliveira
Journal:  Mediators Inflamm       Date:  2017-07-26       Impact factor: 4.711

4.  Secreted aspartyl proteinase (PbSap) contributes to the virulence of Paracoccidioides brasiliensis infection.

Authors:  Daniele Gonçalves Castilho; Alison Felipe Alencar Chaves; Marina Valente Navarro; Palloma Mendes Conceição; Karen Spadari Ferreira; Luiz Severino da Silva; Patricia Xander; Wagner Luiz Batista
Journal:  PLoS Negl Trop Dis       Date:  2018-09-27

5.  Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors: blockage of its enzymatic activity and interference with fungal growth and macrophage interaction.

Authors:  Marcela Q Granato; Ingrid S Sousa; Thabatta L S A Rosa; Diego S Gonçalves; Sergio H Seabra; Daniela S Alviano; Maria C V Pessolani; André L S Santos; Lucimar F Kneipp
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

6.  An Integrated Approach to Identify New Anti-Filarial Leads to Treat River Blindness, a Neglected Tropical Disease.

Authors:  Rahul Tyagi; Christina A Bulman; Fidelis Cho-Ngwa; Chelsea Fischer; Chris Marcellino; Michelle R Arkin; James H McKerrow; Case W McNamara; Matthew Mahoney; Nancy Tricoche; Shabnam Jawahar; James W Janetka; Sara Lustigman; Judy Sakanari; Makedonka Mitreva
Journal:  Pathogens       Date:  2021-01-14

7.  Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans-In Silico, In Vitro and In Vivo Approaches.

Authors:  André L S Santos; Lys A Braga-Silva; Diego S Gonçalves; Lívia S Ramos; Simone S C Oliveira; Lucieri O P Souza; Vanessa S Oliveira; Roberto D Lins; Marcia R Pinto; Julian E Muñoz; Carlos P Taborda; Marta H Branquinha
Journal:  J Fungi (Basel)       Date:  2021-05-28

Review 8.  Candida and Complement: New Aspects in an Old Battle.

Authors:  Verena Harpf; Günter Rambach; Reinhard Würzner; Cornelia Lass-Flörl; Cornelia Speth
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.